
Noble E. Jarrell
Examiner (ID: 13867, Phone: (571)272-9077 , Office: P/1625 )
| Most Active Art Unit | 1699 |
| Art Unit(s) | 1624, 1622, 1625, 1699, 1609, 1629 |
| Total Applications | 1459 |
| Issued Applications | 965 |
| Pending Applications | 172 |
| Abandoned Applications | 340 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15345135
[patent_doc_number] => 20200010459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-09
[patent_title] => PIPERAZINE DERIVATIVES FOR INFLUENZA VIRUS INHIBITIONS
[patent_app_type] => utility
[patent_app_number] => 16/483283
[patent_app_country] => US
[patent_app_date] => 2018-02-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13413
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16483283
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/483283 | Piperazine derivatives for influenza virus inhibitions | Jan 31, 2018 | Issued |
Array
(
[id] => 16696619
[patent_doc_number] => 10947199
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Spiro and cyclic bis-benzylidene proteasome inhibitor for the treatment of cancer, diabetes and neurological disorders
[patent_app_type] => utility
[patent_app_number] => 16/481562
[patent_app_country] => US
[patent_app_date] => 2018-01-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 10
[patent_no_of_words] => 2636
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16481562
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/481562 | Spiro and cyclic bis-benzylidene proteasome inhibitor for the treatment of cancer, diabetes and neurological disorders | Jan 29, 2018 | Issued |
Array
(
[id] => 15293475
[patent_doc_number] => 20190389873
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => DEUTERATED COMPOUND AND MEDICAL USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/484058
[patent_app_country] => US
[patent_app_date] => 2018-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 55
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16484058
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/484058 | Deuterated compound and medical use thereof | Jan 25, 2018 | Issued |
Array
(
[id] => 15290579
[patent_doc_number] => 20190388425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => SUBSTITUTED IMIDAZOPYRIDINPYRIMIDINES
[patent_app_type] => utility
[patent_app_number] => 16/479400
[patent_app_country] => US
[patent_app_date] => 2018-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42466
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16479400
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/479400 | SUBSTITUTED IMIDAZOPYRIDINPYRIMIDINES | Jan 18, 2018 | Abandoned |
Array
(
[id] => 16807786
[patent_doc_number] => 20210130339
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/480839
[patent_app_country] => US
[patent_app_date] => 2018-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 60888
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16480839
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/480839 | COMPOUNDS | Jan 18, 2018 | Abandoned |
Array
(
[id] => 16125811
[patent_doc_number] => 10696645
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-30
[patent_title] => Method for producing purified dialkyl-furan-2,5-dicarboxylate
[patent_app_type] => utility
[patent_app_number] => 15/875352
[patent_app_country] => US
[patent_app_date] => 2018-01-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 17160
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15875352
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/875352 | Method for producing purified dialkyl-furan-2,5-dicarboxylate | Jan 18, 2018 | Issued |
Array
(
[id] => 14057757
[patent_doc_number] => 10233162
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-03-19
[patent_title] => Electronically activated strained alkynes
[patent_app_type] => utility
[patent_app_number] => 15/873984
[patent_app_country] => US
[patent_app_date] => 2018-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 5792
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15873984
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/873984 | Electronically activated strained alkynes | Jan 17, 2018 | Issued |
Array
(
[id] => 12837340
[patent_doc_number] => 20180170953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-06-21
[patent_title] => PROTOTYPE SYSTEMS OF THERANOSTIC BIOMARKERS FOR IN VIVO MOLECULAR MANAGEMENT OF CANCER
[patent_app_type] => utility
[patent_app_number] => 15/866669
[patent_app_country] => US
[patent_app_date] => 2018-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15840
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15866669
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/866669 | Prototype systems of theranostic biomarkers for in vivo molecular management of cancer | Jan 9, 2018 | Issued |
Array
(
[id] => 15775501
[patent_doc_number] => 20200118768
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-16
[patent_title] => COMPOSITIONS AND METHODS OF MAKING METAL-ORGANIC FRAMEWORKS WITH REDOX-ACTIVE CENTERS
[patent_app_type] => utility
[patent_app_number] => 16/471812
[patent_app_country] => US
[patent_app_date] => 2017-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7661
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471812
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/471812 | Compositions and methods of making metal-organic frameworks with redox-active centers | Dec 28, 2017 | Issued |
Array
(
[id] => 15086231
[patent_doc_number] => 20190337926
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-11-07
[patent_title] => BMP-SIGNAL-INHIBITING COMPOUND
[patent_app_type] => utility
[patent_app_number] => 16/473850
[patent_app_country] => US
[patent_app_date] => 2017-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 61768
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 705
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16473850
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/473850 | BMP-signal-inhibiting compound | Dec 25, 2017 | Issued |
Array
(
[id] => 17036630
[patent_doc_number] => 20210253588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-19
[patent_title] => BENZODIAZEPINE DERIVATIVES, COMPOSITIONS, AND METHODS FOR TREATING COGNITIVE IMPAIRMENT
[patent_app_type] => utility
[patent_app_number] => 16/471237
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 79766
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16471237
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/471237 | Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment | Dec 19, 2017 | Issued |
Array
(
[id] => 13300107
[patent_doc_number] => 20180201590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-07-19
[patent_title] => AZOCANE AND AZONANE DERIVATIVES AND METHODS OF TREATING HEPATITIS B INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 15/848639
[patent_app_country] => US
[patent_app_date] => 2017-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22297
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15848639
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/848639 | Azocane and azonane derivatives and methods of treating hepatitis B infections | Dec 19, 2017 | Issued |
Array
(
[id] => 16743258
[patent_doc_number] => 10968232
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-04-06
[patent_title] => Antidiabetic spirochroman compounds
[patent_app_type] => utility
[patent_app_number] => 16/465156
[patent_app_country] => US
[patent_app_date] => 2017-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 65732
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 858
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16465156
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/465156 | Antidiabetic spirochroman compounds | Dec 14, 2017 | Issued |
Array
(
[id] => 12641103
[patent_doc_number] => 20180105532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => HETEROCYCLIC COMPOUNDS AND THEIR USES
[patent_app_type] => utility
[patent_app_number] => 15/841153
[patent_app_country] => US
[patent_app_date] => 2017-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 54426
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15841153
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/841153 | HETEROCYCLIC COMPOUNDS AND THEIR USES | Dec 12, 2017 | Abandoned |
Array
(
[id] => 16381927
[patent_doc_number] => 10806737
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-10-20
[patent_title] => Compounds and methods for the targeted degradation of fetal liver kinase polypeptides
[patent_app_type] => utility
[patent_app_number] => 15/840950
[patent_app_country] => US
[patent_app_date] => 2017-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 12
[patent_no_of_words] => 69734
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 883
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15840950
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/840950 | Compounds and methods for the targeted degradation of fetal liver kinase polypeptides | Dec 12, 2017 | Issued |
Array
(
[id] => 15813941
[patent_doc_number] => 10632127
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-28
[patent_title] => Targeted notch pathway inhibitors
[patent_app_type] => utility
[patent_app_number] => 15/837199
[patent_app_country] => US
[patent_app_date] => 2017-12-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 5
[patent_no_of_words] => 16097
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 234
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15837199
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/837199 | Targeted notch pathway inhibitors | Dec 10, 2017 | Issued |
Array
(
[id] => 17556031
[patent_doc_number] => 11312707
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-04-26
[patent_title] => Compositions and methods for the treatment of fungal infections
[patent_app_type] => utility
[patent_app_number] => 16/464377
[patent_app_country] => US
[patent_app_date] => 2017-11-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 12396
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 197
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16464377
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/464377 | Compositions and methods for the treatment of fungal infections | Nov 23, 2017 | Issued |
| 15/574097 | ENHANCED ANTIBIOTIC COMPOSITION | Nov 13, 2017 | Abandoned |
Array
(
[id] => 16253857
[patent_doc_number] => 20200263231
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => Fluorogenic dyes for high sensitivity DNA detection
[patent_app_type] => utility
[patent_app_number] => 16/340373
[patent_app_country] => US
[patent_app_date] => 2017-11-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20111
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -65
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16340373
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/340373 | Fluorogenic dyes for high sensitivity DNA detection | Oct 31, 2017 | Abandoned |
Array
(
[id] => 14836129
[patent_doc_number] => 20190276465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-12
[patent_title] => Nitrogen-Containing Heterocyclic Compounds As FXR Modulators
[patent_app_type] => utility
[patent_app_number] => 16/346807
[patent_app_country] => US
[patent_app_date] => 2017-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 23783
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -37
[patent_words_short_claim] => 345
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16346807
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/346807 | Nitrogen-containing heterocyclic compounds as FXR modulators | Oct 26, 2017 | Issued |